Abstract:Self-reports of executive performance are generally reliable, but 29% of patients with MS underestimated or overestimated their abilities. It is especially important to identify underestimators as they display underlying psychological problems and dysfunctional coping styles in need of further psychological treatment. Informants are valuable in this respect, but should not be seen as the 'gold standard' to identify cognitive impairment.
“…This is partly consistent with previous studies reporting weak relations between subjective and objective measures of cognitive function in MS (6). It is further in agreement with previous studies suggesting that depressed MS patients may underestimate their cognitive performance (11,12).…”
Section: Discussionsupporting
confidence: 93%
“…Earlier findings by Bruce and Arnett (14) partly supported these results as they found that mildly depressed MS patients underestimated their cognitive performance while moderately depressed patients accurately estimated their cognitive performance. Van der Hiele (6) found that nearly 30% of patients with executive problems either underestimated or overestimated their cognitive abilities. Those who underestimated their performance reported more depression, anxiety, and psychosocial stress.…”
Section: Introductionmentioning
confidence: 99%
“…The symptoms vary from patient to patient (5), but on group level, memory and learning dysfunction, slowed information processing speed and deficits in executive function are common (2). In a recent study of patients with MS (pwMS), nearly 20% reported subjective complaints of executive impairment (6).…”
Among the study variables, depression was the strongest predictor of executive complaints. A high degree of neurological disability was the strongest predictor for executive deficit, measured by neuropsychological tests.
“…This is partly consistent with previous studies reporting weak relations between subjective and objective measures of cognitive function in MS (6). It is further in agreement with previous studies suggesting that depressed MS patients may underestimate their cognitive performance (11,12).…”
Section: Discussionsupporting
confidence: 93%
“…Earlier findings by Bruce and Arnett (14) partly supported these results as they found that mildly depressed MS patients underestimated their cognitive performance while moderately depressed patients accurately estimated their cognitive performance. Van der Hiele (6) found that nearly 30% of patients with executive problems either underestimated or overestimated their cognitive abilities. Those who underestimated their performance reported more depression, anxiety, and psychosocial stress.…”
Section: Introductionmentioning
confidence: 99%
“…The symptoms vary from patient to patient (5), but on group level, memory and learning dysfunction, slowed information processing speed and deficits in executive function are common (2). In a recent study of patients with MS (pwMS), nearly 20% reported subjective complaints of executive impairment (6).…”
Among the study variables, depression was the strongest predictor of executive complaints. A high degree of neurological disability was the strongest predictor for executive deficit, measured by neuropsychological tests.
“…With the growing interest in self assessment scales understanding the background of disagreement is of increasing importance. It has been subject to research before and possible explaining factors are depression, anxiety and caregiver burden [28][29][30].…”
“…All subjects gave informed consent. More details about the main research project can be found in our recent paper on self-reported executive performance in MS [18].…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.